NEPHROGENEX, INC. (a Delaware corporation) [·] Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • April 30th, 2015 • NephroGenex, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 30th, 2015 Company Industry Jurisdiction
SECOND AMENDMENT TO LICENSE AGREEMENTLicense Agreement • April 30th, 2015 • NephroGenex, Inc. • Pharmaceutical preparations
Contract Type FiledApril 30th, 2015 Company IndustryThis Second Amendment to the License Agreement, effective as of this 16th day of March, 2015 (the “Amendment Date”) by and between NephroGenex, Inc., a Delaware corporation having its principal place of business at 2300 Englert Drive, Durham, NC, 27713 (“LICENSEE”) and Vanderbilt University by and through its Center for Technology Transfer and Commercialization, having a principal place of business at 1207 17th Avenue South, Suite 105, Nashville, TN 37212 (hereinafter referred to as “VANDERBILT”),